Nanobiosensors for Rheumatoid Arthritis Biomarkers: Advances and Clinical Translational Potential

Xiaoyong Zhang1, Xuewu Song1, Mingyue Chen1

  • 1Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.

Summary

Nanobiological sensors show promise for detecting rheumatoid arthritis (RA) biomarkers, with lab tests reaching high sensitivity. Clinical use faces challenges, but point-of-care testing for RA is a near-term goal.